Choline metabolism as a basis for the selective vulnerability of cholinergic neurons - PubMed (original) (raw)
Review
Choline metabolism as a basis for the selective vulnerability of cholinergic neurons
R J Wurtman. Trends Neurosci. 1992 Apr.
Abstract
The unique propensity of cholinergic neurons to use choline for two purposes--ACh and membrane phosphatidylcholine synthesis--may contribute to their selective vulnerability in Alzheimer's disease and other cholinergic neurodegenerative disorders. When physiologically active, the neurons use free choline taken from the 'reservoir' in membrane phosphatidylcholine to synthesize ACh; this can lead to an actual decrease in the quantity of membrane per cell. Alzheimer's disease (but not Down's syndrome, or other neurodegenerative disorders) is associated with characteristic neurochemical lesions involving choline and ethanolamine: brain levels of these compounds are diminished, while those of glycerophosphocholine and glycerophosphoethanolamine (breakdown products of their respective membrane phosphatides) are increased, both in cholinergic and noncholinergic brain regions. Perhaps this metabolic disturbance and the tendency of cholinergic neurons to 'export' choline--in the form of ACh--underlie the selective vulnerability of the neurons. Resulting changes in membrane composition could abnormally expose intramembraneous proteins such as amyloid precursor protein to proteases.
Similar articles
- Phosphatidylcholine as a precursor of choline for acetylcholine synthesis.
Blusztajn JK, Liscovitch M, Mauron C, Richardson UI, Wurtman RJ. Blusztajn JK, et al. J Neural Transm Suppl. 1987;24:247-59. J Neural Transm Suppl. 1987. PMID: 3316498 Review. - Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging.
Maire JC, Wurtman RJ. Maire JC, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(4-6):637-42. doi: 10.1016/0278-5846(84)90027-7. Prog Neuropsychopharmacol Biol Psychiatry. 1984. PMID: 6543397 - [Regulation of acetylcholine synthesis in presynaptic endings of cholinergic neurons of the central nervous system].
Tuchek S, Dolezhal V, Richny Ia. Tuchek S, et al. Neirofiziologiia. 1984;16(5):603-11. Neirofiziologiia. 1984. PMID: 6151119 Review. Russian. - Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).
Potter PE, Tedford CE, Kindel G, Hanin I. Potter PE, et al. Brain Res. 1989 May 22;487(2):238-44. doi: 10.1016/0006-8993(89)90828-7. Brain Res. 1989. PMID: 2525061 - Choline transporters, cholinergic transmission and cognition.
Sarter M, Parikh V. Sarter M, et al. Nat Rev Neurosci. 2005 Jan;6(1):48-56. doi: 10.1038/nrn1588. Nat Rev Neurosci. 2005. PMID: 15611726 Review.
Cited by
- Nicotine exposure does not alter plasma to brain choline transfer.
Lockman PR, Gaasch J, McAfee G, Abbruscato TJ, Van der Schyf CJ, Allen DD. Lockman PR, et al. Neurochem Res. 2006 Apr;31(4):503-8. doi: 10.1007/s11064-006-9047-5. Epub 2006 May 9. Neurochem Res. 2006. PMID: 16758358 - Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
Fernández-Cabello S, Kronbichler M, Van Dijk KRA, Goodman JA, Spreng RN, Schmitz TW; Alzheimer’s Disease Neuroimaging Initiative. Fernández-Cabello S, et al. Brain. 2020 Mar 1;143(3):993-1009. doi: 10.1093/brain/awaa012. Brain. 2020. PMID: 32203580 Free PMC article. - Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function.
Varoqui H, Erickson JD. Varoqui H, et al. Mol Neurobiol. 1997 Oct;15(2):165-91. doi: 10.1007/BF02740633. Mol Neurobiol. 1997. PMID: 9396009 Review. - Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Poirier J, et al. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12260-4. doi: 10.1073/pnas.92.26.12260. Proc Natl Acad Sci U S A. 1995. PMID: 8618881 Free PMC article. - Exploring temporospatial changes in glucose metabolic disorder, learning, and memory dysfunction in a rat model of diffuse axonal injury.
Li J, Gu L, Feng DF, Ding F, Zhu G, Rong J. Li J, et al. J Neurotrauma. 2012 Nov 20;29(17):2635-46. doi: 10.1089/neu.2012.2411. J Neurotrauma. 2012. PMID: 22880625 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources